Healthcare Innovation December 13, 2022
David Raths

Genomics England, in partnership with the NHS, will evaluate genomic sequencing technology to improve the accuracy and speed of diagnosis for cancer patients

The UK government has announced a £175 million investment in genomics research, including a study led by Genomics England, in partnership with the National Health Service (NHS), to explore the effectiveness of using whole-genome sequencing to find and treat rare genetic diseases in newborn babies.

For example, rare genetic thyroid hormone conditions, which are not detectable by the routine NHS heel prick test, and can cause developmental and learning difficulties and longer-term health complications without treatment. The study will sequence the genomes of 100,000 babies over...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Pharma / Biotech, Precision Medicine, Provider
Related Articles:
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article